Display options
Share it on

J Clin Rheumatol. 2022 Jan 01;28(1):e118-e124. doi: 10.1097/RHU.0000000000001658.

Risk Factors for Spinal Structural Damage in a Chinese Cohort With Ankylosing Spondylitis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Weiping Kong, Caroline Jefferies, Thomas J Learch, Xiaowei Gan, Feng Zhu, Nan Zhang, Dier Jin, Yingze Zhang, Qingwen Tao, Xiaoping Yan, Mariko L Ishimori, Michael H Weisman

Affiliations

  1. Division of Rheumatology, Department of Medicine.
  2. Department of Radiology, Cedars-Sinai Medical Center, Los Angeles, CA.
  3. Department of Traditional Chinese Medicine Rheumatology, Guangdong Second Hospital of Traditional Chinese Medicine, Guangzhou, China.
  4. Neuroanatomical Department, Hyogo College of Medicine, Nishinomiya, Japan.
  5. From the Department of Traditional Chinese Medicine Rheumatology.

PMID: 33394829 DOI: 10.1097/RHU.0000000000001658

Abstract

OBJECTIVES: A cross-sectional study was conducted in 270 Chinese patients with ankylosing spondylitis (AS) in order to identify potential risk factors for severity of spinal structural damage.

METHODS: Two hundred seventy AS patients fulfilled the Modified New York Criteria. Computed tomography (CT) was used to scan sacroiliac and hip joints, and radiography was used to scan anteroposterior and lateral lumbar spine, as well as lateral cervical spine. Bath Ankylosing Spondylitis Radiology Index and modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) were scored in duplicate.

RESULTS: One hundred eighty-three patients had low mSASSS (mSASSS, <10), and 87 patients had high mSASSS (mSASSS, ≥10). Univariate analysis revealed that AS age of onset, body mass index (BMI), smoking duration, duration of symptoms, diagnostic delay, hip involvement, and sacroiliitis grade were significantly associated with the risk of having high mSASSS after adjustment (all p's < 0.05). Hip involvement interacted significantly with BMI and smoking duration in a graded manner. Particularly, relative to patients with low BMI-negative hip involvement, those with high BMI-negative hip involvement, low BMI-positive hip involvement, and high BMI-positive hip involvement had a 1.94-fold, 3.29-fold, and 5.07-fold increased risk of high mSASSS (95% confidence interval, 0.84-4.47, 1.37-7.89, and 1.97-13.06, p = 0.118, 0.008, and 0.001, respectively). Finally, a nomogram graph based on 7 significant risk factors was generated with substantial prediction accuracy (concordance index, 0.906).

CONCLUSIONS: We have identified 7 potential risk factors for the severity of spinal structural damage in Chinese AS patients. Importantly, positive hip involvement, combined with high BMI or long smoking duration, was associated with a remarkably increased risk of having severe spinal structural damage.

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Watad A, Bridgewood C, Russell T, et al. The early phases of ankylosing spondylitis: emerging insights from clinical and basic science. Front Immunol. 2018;9:2668. - PubMed
  2. Schett G, Coates LC, Ash ZR, et al. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future. Arthritis Res Ther. 2011;13(Suppl 1):S4. - PubMed
  3. Dean LE, Jones GT, MacDonald AG, et al. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014;53:650–657. - PubMed
  4. Sieper J. Can structural damage be prevented in ankylosing spondylitis? Curr Opin Rheumatol 2009;21:335–339. - PubMed
  5. Villaverde-García V, Cobo-Ibáñez T, Candelas-Rodríguez G, et al. The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: a systematic literature review. Semin Arthritis Rheum. 2017;46:569–583. - PubMed
  6. Bakirci S, Dabague J, Eder L, et al. The role of obesity on inflammation and damage in spondyloarthritis: a systematic literature review on body mass index and imaging. Clin Exp Rheumatol. 2020;38:144–148. - PubMed
  7. Bergman M, Lundholm A. Managing morbidity and treatment-related toxicity in patients with ankylosing spondylitis. Rheumatology (Oxford). 2018;57:419–428. - PubMed
  8. Magrey MN, Khan MA. The paradox of bone formation and bone loss in ankylosing spondylitis: evolving new concepts of bone formation and future trends in management. Curr Rheumatol Rep. 2017;19:17. - PubMed
  9. Kim JW, Chung MK, Lee J, et al. Low bone mineral density of vertebral lateral projections can predict spinal radiographic damage in patients with ankylosing spondylitis. Clin Rheumatol. 2019;38:3567–3574. - PubMed
  10. Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis. 2015;74:52–59. - PubMed
  11. Jamalyaria F, Ward MM, Assassi S, et al. Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups. Clin Rheumatol. 2017;36:2359–2364. - PubMed
  12. Lopez-Medina C, Garrido-Castro JL, Castro-Jimenez J, et al. Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage. Clin Rheumatol. 2018;37:1581–1588. - PubMed
  13. Protopopov M, Sieper J, Haibel H, et al. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Res Ther. 2017;19:240. - PubMed
  14. Ramiro S, van der Heijde D, van Tubergen A, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis. 2014;73:1455–1461. - PubMed
  15. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–368. - PubMed
  16. van der Heijde D, Calin A, Dougados M, et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. Assessments in ankylosing spondylitis. J Rheumatol. 1999;26:951–954. - PubMed
  17. Lukas C, Landewé R, Sieper J, et al. Development of an ASAS-Endorsed Disease Activity Score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68:18–24. - PubMed
  18. Garrett S, Jenkinson T, Kennedy LG, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286–2291. - PubMed
  19. MacKay K, Brophy S, Mack C, et al. The development and validation of a radiographic grading system for the hip in ankylosing spondylitis: the bath ankylosing spondylitis radiology hip index. J Rheumatol. 2000;27:2866–2872. - PubMed
  20. Creemers MC, Franssen MJ, van't Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005;64:127–129. - PubMed
  21. MacKay K, Mack C, Brophy S, et al. The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum. 1998;41:2263–2270. - PubMed
  22. Lee JS, Song YW, Kim TH, et al. Baseline extent of damage predicts spinal radiographic progression in Korean patients with ankylosing spondylitis treated with golimumab. Korean J Intern Med. 2018;33:622–628. - PubMed
  23. Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364–1370. - PubMed
  24. Akar S, Kaplan YC, Ecemiş S, et al. The role of smoking in the development and progression of structural damage in axial SpA patients: a systematic review and meta-analysis. Eur J Rheumatol. 2018;6:184–192. - PubMed
  25. Chung HY, Machado P, van der Heijde D, et al. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis. 2012;71:809–816. - PubMed
  26. Wanders AJ, Landewé RB, Spoorenberg A, et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter. Arthritis Rheum. 2004;50:2622–2632. - PubMed
  27. van der Heijde D, Braun J, Deodhar A, et al. Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology (Oxford). 2019;58:388–400. - PubMed
  28. Jeong H, Bea EK, Lee J, et al. Body mass index and estrogen predict radiographic progression in the spine in ankylosing spondylitis. Joint Bone Spine. 2015;82:473–474. - PubMed
  29. Salvadorini G, Bandinelli F, Delle Sedie A, et al. Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades. Clin Exp Rheumatol. 2012;30:561–565. - PubMed
  30. Ramiro S, Landewe R, van Tubergen A, et al. Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open. 2015;1:e000153. - PubMed
  31. Chen HA, Chen CH, Liao HT, et al. Factors associated with radiographic spinal involvement and hip involvement in ankylosing spondylitis. Semin Arthritis Rheum. 2011;40:552–558. - PubMed
  32. Poddubnyy D, Haibel H, Listing J, et al. Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis inception cohort (GESPIC). Ann Rheum Dis. 2013;72:1430–1432. - PubMed
  33. Bandinelli F, Salvadorini G, Delle Sedie A, et al. Impact of gender, work, and clinical presentation on diagnostic delay in Italian patients with primary ankylosing spondylitis. Clin Rheumatol. 2016;35:473–478. - PubMed
  34. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006;54:569–578. - PubMed
  35. Wink F, Arends S, Maas F, et al. High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis. Rheumatology (Oxford). 2019;58:1040–1046. - PubMed
  36. Chen CH, Chen HA, Lu CL, et al. Association of cigarette smoking with Chinese ankylosing spondylitis patients in Taiwan: a poor disease outcome in systemic inflammation, functional ability, and physical mobility. Clin Rheumatol. 2013;32:659–663. - PubMed
  37. Rai MF, Sandell LJ. Inflammatory mediators: tracing links between obesity and osteoarthritis. Crit Rev Eukaryot Gene Expr. 2011;21:131–142. - PubMed
  38. Ward MM, Reveille JD, Learch TJ, et al. Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis. Arthritis Rheum. 2008;59:822–832. - PubMed
  39. Cambre I, Gaublomme D, Burssens A, et al. Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis. Nat Commun. 2018;9:4613. - PubMed
  40. Jacques P, Lambrecht S, Verheugen E, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73:437–445. - PubMed
  41. Kehl AS, Corr M, Weisman MH. Review: enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment. Arthritis Rheumatol. 2016;68:312–322. - PubMed
  42. Vander Cruyssen B, Munoz-Gomariz E, Font P, et al. Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford). 2010;49:73–81. - PubMed
  43. Fritz P, Rieden K, Lenarz T, et al. Radiological evaluation of temporal bone disease: high-resolution computed tomography versus conventional x-ray diagnosis. Br J Radiol. 1989;62:107–113. - PubMed
  44. Jeong H, Eun YH, Kim IY, et al. Characteristics of hip involvement in patients with ankylosing spondylitis in Korea. Korean J Intern Med. 2017;32:158–164. - PubMed
  45. Devauchelle-Pensec V, D'Agostino MA, Marion J, et al. Computed tomography scanning facilitates the diagnosis of sacroiliitis in patients with suspected spondylarthritis: results of a prospective multicenter French cohort study. Arthritis Rheum. 2012;64:1412–1419. - PubMed
  46. Geijer M, Gothlin GG, Gothlin JH. The clinical utility of computed tomography compared to conventional radiography in diagnosing sacroiliitis. A retrospective study on 910 patients and literature review. J Rheumatol. 2007;34:1561–1565. - PubMed
  47. Tan S, Yao J, Flynn JA, et al. Quantitative measurement of syndesmophyte volume and height in ankylosing spondylitis using CT. Ann Rheum Dis. 2014;73:544–550. - PubMed
  48. de Koning A, de Bruin F, van den Berg R, et al. Low-dose CT detects more progression of bone formation in comparison to conventional radiography in patients with ankylosing spondylitis: results from the SIAS cohort. Ann Rheum Dis. 2018;77:293–299. - PubMed
  49. Stal R, van Gaalen F, Sepriano A, et al. Facet joint ankylosis in r-axSpA: detection and 2-year progression on whole spine low-dose CT and comparison with syndesmophyte progression. Rheumatology (Oxford). 2020. - PubMed

Publication Types